Mechanistically, CD44V3 expression was downregulated by splicing factor U2AF1, an important component of the spliceosome, and the expression of U2AF1 was reduced in pancreatic cancer cells and tissues [27,28]. The gene discussed is U2AF1; the disease is familial pancreatic carcinoma.